The high frequency of KRAS mutations in serrated adenomas and serrated adenocarcinomas observed in the present study explains, in part, why KRAS mutations are less frequent in non-serrated adenomas but occur in abount 40% of CRCs. This evidence concerns the gene KRAS and adenoma.